CEO Kim Rivers Files Intent to Sell $17.8M in Trulieve Cannabis Stock
TRLV has more than doubled off its 52-week low of $3.25 on light trading volume (0.2× avg).
Summary
Trulieve Cannabis CEO Kim Rivers has filed to sell $17.8 million in company stock, a notable transaction that could signal executive sentiment.
Key Events · Ownership and Investor Activity · TRLV
-
CEO Files Intent to Sell Shares
Kim Rivers, CEO and a 10% stockholder, filed a Form 144 to sell 1,699,007 shares of Trulieve Cannabis Corp. stock.
-
Significant Transaction Value
The proposed sale has an approximate market value of $17,839,574.00, representing a substantial portion of the company's market capitalization.
-
Executive Sentiment Signal
This intent to sell by a top executive could be viewed negatively by investors, particularly given the recent departure of the company's President.
Analysis · TRLV · Life Sciences
Kim Rivers, CEO and a 10% stockholder of Trulieve Cannabis Corp., has filed a Form 144 indicating her intent to sell approximately $17.8 million worth of company stock. This represents a significant portion of the company's market capitalization and could be interpreted as a lack of confidence by a key executive, especially following the recent departure of the company's President.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TRLV was trading at $9.73 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $3.25 to $13.28. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.